Chemoinformaics analysis of 3,3-Dimethylpentane
| Molecular Weight | 100.205 | nRot | 2 |
| Heavy Atom Molecular Weight | 84.077 | nRig | 1 |
| Exact Molecular Weight | 100.125 | nRing | 0 |
| Solubility: LogS | -3.218 | nHRing | 0 |
| Solubility: LogP | 4.126 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 22.3587 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.438 |
| Synth | 2.123 |
| Natural Product Likeliness | 1.833 |
| NR-PPAR-gamma | 0.021 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.192 |
| HIA | 0.004 |
| CACO-2 | -4.294 |
| MDCK | 0.0000239 |
| BBB | 0.845 |
| PPB | 0.949803 |
| VDSS | 1.498 |
| FU | 0.0564964 |
| CYP1A2-inh | 0.924 |
| CYP1A2-sub | 0.249 |
| CYP2c19-inh | 0.241 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.267 |
| CYP2c9-sub | 0.913 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.19 |
| CYP3a4-inh | 0.083 |
| CYP3a4-sub | 0.086 |
| CL | 8.134 |
| T12 | 0.639 |
| hERG | 0.046 |
| Ames | 0.011 |
| ROA | 0.035 |
| SkinSen | 0.955 |
| Carcinogencity | 0.135 |
| EI | 0.98 |
| Respiratory | 0.273 |
| NR-Aromatase | 0.042 |
| Antiviral | No |
| Prediction | 0.954439 |